About
Company Strategy
Group Structure
Board of directors
Management
Career
Contacts
Development
Drugs
Medical devices
Medical services
Biotech valuation
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Investor
Disclosure of information
News
En
RU
CN
Главная
News
News
News, press releases, events, publications
All categories
All categories
News
Press releases
Press about us
Portfolio
Portfolio
Genetico
Gemabank
Histograft
Nextgen
Genotarget
Biotechnology Developments
Betuvax
Reprobank
Vitacel
16.06.2023
Press releases
Betuvax-CoV-2 vaccine to undergo phase 3 clinical trial
15.06.2023
Press releases
The gene therapy drug developer opens a new laboratory at Medtech Technopark
09.06.2023
News
Russia’s genetic embryo testing market valued at $13.05 million
24.05.2023
Press releases
RBT’s pre-IPO orders are oversubscribed
19.05.2023
Press releases
Genetico to open a medical center at Medtech Moscow
18.05.2023
Press releases
HSCI’s performance for 2022 according to IFRS
10.05.2023
Press releases
Genetico’s shares have been listed as high-tech economy sector securities
1
…
9
10
11
12
13
14
Up
About the Company
About
Company Strategy
Group Structure
Board of Directors
Management
Career
Contacts
Development Portfolio
Drugs
Medical Devices
Medical Services
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Biotech Valuation
Investors
Disclosure of information
